OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
58
Results
Show all
Save search
Copy query
Show results for
Unknown
(58)
Publication Date
Release Date
2025
(15)
2024
(11)
2022
(7)
2021
(5)
2023
(4)
2020
(3)
2016
(3)
2011
(3)
2026
(2)
2019
(2)
2010
(2)
2018
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Airway insertion first pass success and patient outcomes in adult out-of-hospital cardiac arrest: The Pragmatic Airway Resuscitation Trial.
Not available
S-EPMC7855546
|
biostudies-literature
Cite
Burden of Ischemic and Hemorrhagic Stroke Across the US From 1990 to 2019.
Not available
S-EPMC10913004
|
biostudies-literature
Cite
Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial.
Not available
S-EPMC12865694
|
biostudies-literature
Cite
Global burden of peripheral artery disease and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
Not available
S-EPMC10522777
|
biostudies-literature
Cite
Global, regional, and national burden of headache disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12612381
|
biostudies-literature
Cite
Global, regional, and national burden of headache disorders, 1990-2021, with forecasts to 2050: A Global Burden of Disease study 2021.
Not available
S-EPMC12629824
|
biostudies-literature
Cite
Long Covid: a global health issue - a prospective, cohort study set in four continents.
Not available
S-EPMC11552006
|
biostudies-literature
Cite
Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial.
Not available
S-EPMC12824789
|
biostudies-literature
Cite
Global, regional, and national burden of epilepsy, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Not available
S-EPMC11876103
|
biostudies-literature
Cite
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis.
Not available
S-EPMC10278789
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets